Loe ja kuula

Astu lugude lõputusse maailma

  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Suurim valik eestikeelseid raamatuid
  • Kokku üle 700 000 raamatu 4 keeles
Proovi tasuta
Device Banner Block-copy 894x1036
Cover for Genentech: The Beginnings of Biotech

Genentech: The Beginnings of Biotech

3 hinnangut

4.3

Kestus
7 h 12 min
Keel
inglise
Vorming
Kategooria

Teadmiskirjandus

“Skillfully describes the improbable creation, difficult adolescence, immense prosperity, and eventual foundering of . . . the first biotech behemoth.” —Daniel S. Greenberg, author of Tech Transfer

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.

Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech’s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech’s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.

Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.

© 2021 Tantor Media (Audioraamat): 9781666144680
© 2024 The University of Chicago Press (E-raamat): 9780226359205

Väljaandmise kuupäev

Audioraamat: 28. september 2021
E-raamat: 31. mai 2024

Sildid

Vali pakett

  • Kokku üle 700 000 raamatu 4 keeles

  • Suur valik eestikeelseid raamatuid

  • Uusi raamatuid iga nädal

  • Kids Mode lastesõbralik keskkond

Populaarne

Unlimited

14.99 € /kuus
  • 1 konto

  • Kuula ja loe piiramatult

  • Tühista igal ajal

Proovi kohe

Unlimited (aastane)

119.99 € /aasta
  • 1 konto

  • Kuula ja loe piiramatult

  • Säästa 33%

Proovi kohe